Washington, President Donald Trump signed an executive order Thursday to reclassify marijuana from a Schedule I to Schedule III controlled substance, the White House and multiple news outlets reported. The order directs the attorney general and DEA to implement rescheduling, potentially easing research restrictions, reducing tax burdens on some cannabis businesses, and altering enforcement priorities while federal illegality would remain. Officials and industry representatives cited potential benefits for patients, veterans and medical research. The DEA and Justice Department retain implementation authority and timing. Federal agencies will publish timelines and technical review details. Based on 7 articles reviewed and supporting research.
This 60-second summary was prepared by the JQJO editorial team after reviewing 7 original reports from WTNH, CBS News, PBS.org, Pulse24.com, http://www.wtol.com, 7 News Miami and New York Post.
Medical researchers, some cannabis businesses, veterans and patients could see eased research access and reduced regulatory burdens if agencies implement rescheduling and related guidance.
Entities relying on current federal enforcement regimes, some law enforcement units, and parts of the illicit market may face operational and regulatory disruption as rules and priorities shift.
After reading and researching latest news.... Rescheduling moves marijuana to Schedule III, directing DOJ and DEA to initiate review. The change may ease research barriers, affect federal tax treatment, and shift enforcement priorities; federal illegality remains until regulatory and statutory adjustments occur under agency timelines, and potential banking reforms follow.
No left-leaning sources found for this story.
Trump Signs Executive Order Rescheduling Marijuana Federally
WTNH CBS News PBS.org Pulse24.com http://www.wtol.com 7 News Miami
Comments